Use of contrast-enhanced ultrasound imaging to detect the first draining lymph node (FDLN) in a swine model: Correlation of imaging findings with the distance from the injection site to the FDLN

Journal of Ultrasound in Medicine

Volumn 27, Issue 8, 2008, Pages 1203-1209

  Nielsen, Kristina R ^a,c   Grossjohann, Hanne S ^a   Hansen, Carsten P ^b   Nielsen, Michael B ^a  

^a Section of Ultrasound

^b Department of Gastroenterological Surgery ^*

^c Rigshospitalet   (Denmark)

Author keywords

Contrast agent; Lymph node; Sentinel node; Ultrasound

Indexed keywords

BODY FLUIDS; BUBBLES (IN FLUIDS); SULFUR HEXAFLUORIDE; ULTRASONIC IMAGING; ULTRASONICS;

CONTRAST AGENT; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; LOW MECHANICAL INDEX; LYMPH NODE; LYMPHATIC CHANNELS; SENTINEL NODE; ULTRASOUND CONTRAST AGENT;

ULTRASONIC APPLICATIONS;

CONTRAST MEDIUM; DYE; SULFUR HEXAFLUORIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; EUTHANASIA; LYMPH NODE; LYMPHATIC SYSTEM; MICROBUBBLE; NECK; NONHUMAN; ULTRASOUND;

EID: 48949106354     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2008.27.8.1203     Document Type: Article

References (25)

1. Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR. Sentinel node biopsy for melanoma: a study of 241 patients. Melanoma Res 2004; 14:521-526.
2. Tanis PJ, Níeweg OE, Valdés Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast Cancer Res 2001; 3:109-112.
3. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7:87-97.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-983.
5. Goldberg BB, Merton DA, Liu JB, et al. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004; 230:727-734.
6. Goldberg BB, Merton DA, Liu JB, Murphy G, Forsberg F. Contrast-enhanced sonographic imaging of lymphatic channels and sentinel lymph nodes. J Ultrasound Med 2005; 24:953-965.
7. Lock-Andersen J, Horn J, Sjøstrand H, Nurnberg BM, Stokholm KH. Sentinel node biopsy in cutaneous melanoma. Scand J Plast Reconstr Surg Hand Surg 2006; 40:24-31.
8. Mattrey RF, Kono Y, Baker K, Peterson T. Sentinel lymph node imaging with microbubble ultrasound contrast material. Acad Radiol 2002; 9(suppl 1):S231-S235.
9. Balega J, Van Trappen PO. The sentinel node in gynaecological malignancies. Cancer Imaging 2006; 6:7-15.
10. Busby JE, Pettaway CA. What's new in the management of penile cancer? Curr Opin Urol 2005; 15:350-357.
11. Chakera AH, Friis E, Hesse U, Al Suliman N, Zerahn B, Hesse B. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005; 32:286-293.
12. Hakim AA, Terada KY. Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol 2006; 7:85-91.
13. Kroon BK, Valdés Olmos RA, van Tinteren H, Nieweg OE, Horenblas S. Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. J Urol 2005; 174:2214-2217.
14. Wisner ER, Ferrara KW, Short RE, Ottoboni TB, Gabe JD, Patel D. Sentinel node detection using contrast-enhanced power Doppler ultrasound lymphography. Invest Radiol 2003; 38:358-365.
15. Clement O, Luciani A. Imaging the lymphatic system: possibilities and clinical applications. Eur Radiol 2004; 14:1498-1507.
16. Lurie DM, Seguin B, Schneider PD, Verstraete FJ, Wisner ER. Contrast-assisted ultrasound for sentinel lymph node detection in spontaneously arising canine head and neck tumors. Invest Radiol 2006; 41:415-421.
17. Omoto K, Mizunuma H, Ogura S, et al. New method of sentinel node identification with ultrasonography using albumin as contrast agent: a study in pigs. Ultrasound Med Biol 2002; 28:1115-1122.
18. Wisner ER, Ferrara K, Gabe JD, et al. Contrast enhanced intermittent power Doppler ultrasound with sub-micron bubbles for sentinel node detection. Acad Radiol 2002; 9(suppl 2):S389-S391.
19. Weskott HP, Dietrich CF, Rossknecht A. Contrast-Enhanced Volume Ultrasound. Chalfont St Giles, England: GE Healthcare; 2007. Pamphlet 300-07-U024E.
20. European Medicines Agency. EPARs for authorised medicinal products for human use: SonoVue. Annex I: summary of product characteristics. European Medicines Agency website. http://www.emea.europa.eu/humandocs/humans/epar/ sonovue/sonovue.htm.
21. Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Ishihara M, Fujimaki M. Gray-scale liver enhancement with Sonazoid (NC 100100), a novel ultrasound contrast agent: detection of hepatic tumors in a rabbit model. Biol Pharm Bull 2003; 26:1272-1277.
22. European Medicines Agency. EPARs for authorised medicinal products for human use: Luminity. Annex I: summary of product characteristics. European Medicines Agency website. http://www.emea.europa.eu/humandocs/humans/epar/ luminity/luminity.htm.
23. Daiichi Sankyo Co Ltd. Ultrasound contrast medium Sonazoid® gets import approval. Daiichi Sankyo Co Ltd website. http://www.daiichisankyo.com/ news/yymmdd_nn.html?b_newsrelease_n1_eng.detail[id]=223.3&b_ newsrelease_n1_eng.year_selector[id]=223.3&b_ newsrelease_n1_eng. category_selector[id]=223.3.
24. Dyce KM, Sack WO, Wensing CJG. Textbook of Veterinary Anatomy. 2nd ed. Philadelphia, PA: WB Saunders Co; 1996.
25. Nickel R, Schummer A, Scieferk E. Lehrbuch der Anatomie der Haustiere. 4th ed. Berlin, Germany: Parey Buchverlag; 2005.